Frequency of Factor V (1691 G → A) Mutation in Turkish Population

• References

• 1 Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, Van derVede PA, Reitsma PH. Mutation in blood coagulation Factor V associated with resistance to activated protein C. Nature 1994; 369: 64-67
• 2 Koster T, Rosendaal FR, de Ronde H, Briet E, Vandenbroucke JP, Bertina RM. Venous thrombosis due to poor anticoagulant respanse to activated protein C: Leiden Thrombophilia Study. Lancet 1993; 342: 1503-1506
• 3 Bertina RM, Reitsma RH, Rosendaal FR, Vandenbroucke JP. Resistance to activated protein C and factor V Leiden as risk factors for venous thrombosis. Thromb Haemost 1995; 74: 449-553
• 4 Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet 1995; 346: 1133
• 5 Fujimura H, KambayashiJ Monden, Kato H, Miyata T. Coagulation Factor V Leiden mutation may have a racial background. Thromb Haemost 1996; 74: 1381-1382
• 6 Beauchamp NJ, Daly ME, Hampton KK, Cooper PC, Preston FE, Peale IR. High prevalence of a mutation in the Factor V gene within the UK population: relationship to activated protein C resistance and familial thrombosis. Br J Haematol 1994; 88: 219-222
• 7 Gürgey A, Mesci L, Renda Y, Olcay L, Koçak N, Erdem G. Factor V Q 506 Mutation in Children with Thrombosis. Am J Hematol 1996; 53: 37-38
• 8 Gül A, Özbek U, Öztürk C, Inanç M, Koniçe M, Özçelik T. Coagulation Factor V Gene Mutation increases the risk of venous thrombosis in Behçet’s Disease. Br J Rheumatology 1996; 35: 1178-1180
• 9 Gandrille S, Alhenc-Gelas M, Aiach M. A rapid screening method for the Factor V Arg 506 → Gln mutation. Blood Coagul Fibrinolysis 1995; 6: 245-248
• 10 Chaida C, Gialeraki A, Tsoukala C, Mandalaki T. Prevalence of the FVQ506 Mutation in the Hellenic Population. Thromb Haemost 1994; 73: 739-742
• 11 Cin Ş, Akar N, Arcasoy A, Dedeoğlu S, Çavdar AO. Prevalence of Thalassemia and G6PD Deficiency in North Cyprus. Acta Haemat 1984; 71: 69-70